文献速递流行病学与生物统计基础与转化研究

既往登革病毒感染与寨卡风险:尼加拉瓜儿童队列研究

Prior dengue virus infection and risk of Zika: A pediatric cohort in Nicaragua.
PubMed 文献 · PLoS Med · 2019-01-22

在尼加拉瓜马那瓜约3700名2-14岁儿童社区队列中,2016年寨卡疫情期间识别560例症状性寨卡感染和1356例总感染。分析3027名有明确登革感染史儿童发现,既往登革感染与症状性寨卡感染风险降低相关(IRR 0.63)。

要点

  • 既往登革感染与症状性寨卡风险降低相关(IRR 0.63)。
  • 既往或近期登革感染不影响寨卡总感染率。
  • 结论限于儿童队列,需进一步研究免疫机制。

核心结论

  • 既往登革病毒感染可能保护个体免于症状性寨卡。

研究设计与样本

  • 社区为基础的儿童队列研究,随访约3700名2-14岁儿童,使用年度血样和血清学检测识别无症状寨卡感染。

主要发现

  • 2016年1月1日至2017年2月28日识别560例症状性寨卡感染和1356例总感染。
  • 症状性感染总发病率为14.0例/100人年(95% CI: 12.9, 15.2),总感染为36.5例/100人年(95% CI: 34.7, 38.6)。
  • 有效再生数估计范围为3.3至3.4。
  • 在3027名有明确登革感染史参与者中,743名(24.5%)至少有一次既往登革感染;既往登革感染与症状性寨卡风险负相关(IRR: 0.63; 95% CI: 0.48, 0.81; p < 0.005)。
  • 调整年龄、性别和近期登革感染后,既往登革感染与寨卡感染后出现症状的风险负相关(IRR: 0.62; 95% CI: 0.44, 0.86)。

临床怎么用

  • 提示既往登革感染史可能用于评估个体症状性寨卡风险,但需更多研究验证。

局限性

  • 发现仅限于儿童人群,并受研究地点流行病学特征限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Zika virus (ZIKV) emerged in northeast Brazil in 2015 and spread rapidly across the Americas, in populations that have been largely exposed to dengue virus (DENV). The impact of prior DENV infection on ZIKV infection outcome remains unclear. To study this potential impact, we analyzed the large 2016 Zika epidemic in Managua, Nicaragua, in a pediatric cohort with well-characterized DENV infection histories. METHODS AND FINDINGS: Symptomatic ZIKV infections (Zika cases) were identified by real-time reverse transcription PCR and serology in a community-based cohort study that follows approximately 3,700 children aged 2-14 years old. Annual blood samples were used to identify clinically inapparent ZIKV infections using a novel, well-characterized serological assay. Multivariable Poisson regression was used to examine the relation between prior DENV infection and incidence of symptomatic and inapparent ZIKV infection. The generalized-growth method was used to estimate the effective reproduction number. From January 1, 2016, to February 28, 2017, 560 symptomatic ZIKV infections and 1,356 total ZIKV infections (symptomatic and inapparent) were identified, for an overall incidence of 14.0 symptomatic infections (95% CI: 12.9, 15.2) and 36.5 total infections (95% CI: 34.7, 38.6) per 100 person-years. Effective reproduction number estimates ranged from 3.3 to 3.4, depending on the ascending wave period. Incidence of symptomatic and total ZIKV infections was higher in females and older children. Analysis of the effect of prior DENV infection was performed on 3,027 participants with documented DENV infection histories, of which 743 (24.5%) had experienced at least 1 prior DENV infection during cohort follow-up. Prior DENV infection was inversely associated with risk of symptomatic ZIKV infection in the total cohort population (incidence rate ratio [IRR]: 0.63; 95% CI: 0.48, 0.81; p < 0.005) and with risk of symptomatic presentation given ZIKV infection (IRR: 0.62; 95% CI: 0.44, 0.86) when adjusted for age, sex, and recent DENV infection (1-2 years before ZIKV infection). Recent DENV infection was significantly associated with decreased risk of symptomatic ZIKV infection when adjusted for age and sex, but not when adjusted for prior DENV infection. Prior or recent DENV infection did not affect the rate of total ZIKV infections. Our findings are limited to a pediatric population and constrained by the epidemiology of the site. CONCLUSIONS: These findings support that prior DENV infection may protect individuals from symptomatic Zika. More research is needed to address the possible immunological mechanism(s) of cross-protection between ZIKV and DENV and whether DENV immunity also modulates other ZIKV infection outcomes such as neurological or congenital syndromes.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Gordon A, Gresh L, Ojeda S, et al. Prior dengue virus infection and risk of Zika: A pediatric cohort in Nicaragua. PLoS Med. 2019. PMID: 30668565. doi:10.1371/journal.pmed.1002726

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。